Iterum Therapeutics to Participate in H.C. Wainwright BioConnect Virtual Conference
DUBLIN, Ireland and CHICAGO, Jan. 06, 2021 (GLOBE NEWSWIRE) — Iterum Therapeutics plc (Nasdaq: ITRM) (the Company), a clinical-stage pharmaceutical
Read moreDUBLIN, Ireland and CHICAGO, Jan. 06, 2021 (GLOBE NEWSWIRE) — Iterum Therapeutics plc (Nasdaq: ITRM) (the Company), a clinical-stage pharmaceutical
Read moreDUBLIN, Ireland and CHICAGO, Jan. 06, 2021 (GLOBE NEWSWIRE) — Iterum Therapeutics plc (Nasdaq: ITRM) (the Company), a clinical-stage pharmaceutical
Read more–Dr. Dunne resigns as Chief Scientific Officer– — Steven Aronin, M.D., Senior Vice President and Head of Clinical Development, to
Read more—First Oral Penem in the U.S. and First New Oral Treatment for uUTIs in Over 20 Years, if approved–– ––Potential
Read moreDUBLIN, Ireland and CHICAGO, Oct. 23, 2020 (GLOBE NEWSWIRE) — Iterum Therapeutics plc (Nasdaq: ITRM), a clinical-stage pharmaceutical company focused
Read moreData presentations to cover both SURE-1 and SURE-2 urinary tract infection studies DUBLIN, Ireland and CHICAGO, Oct. 19, 2020 (GLOBE
Read moreData presentations to cover both SURE-1 and SURE-2 urinary tract infection studies DUBLIN, Ireland and CHICAGO, Oct. 19, 2020 (GLOBE
Read moreDUBLIN, Ireland and CHICAGO, Sept. 08, 2020 (GLOBE NEWSWIRE) — Iterum Therapeutics plc (Nasdaq: ITRM) (the “Company”), a clinical-stage pharmaceutical
Read moreDUBLIN, Ireland and CHICAGO, Sept. 08, 2020 (GLOBE NEWSWIRE) — Iterum Therapeutics plc (Nasdaq: ITRM) (the “Company”), a clinical-stage pharmaceutical
Read moreDUBLIN, Ireland and CHICAGO, Sept. 08, 2020 (GLOBE NEWSWIRE) — Iterum Therapeutics plc (Nasdaq: ITRM) (the “Company”), a clinical-stage pharmaceutical
Read more